Scientists identify promising immunotherapy combination for pediatric brain cancer

(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys have discovered that combining immunotherapy with a drug called tumor necrosis factor (TNF) eradicated a deadly type of pediatric brain tumor in mice. The discovery, published in Nature Neuroscience, is expected to lead to a clinical trial to test the benefits of the treatment in patients. The findings also hold implications for other cancers that do not respond to immunotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news